Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-05

Clinical Trial Update: Pelashield™ PainGuard™ vs Restrata® in HS Surgery [NA]

View source ↗

Summary

This clinical trial compares Pelashield PainGuard with Restrata in the surgical management of hidradenitis suppurativa and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pelashield PainGuard
  • Restrata

Snippet

Sponsor: Rutgers, The State University of New Jersey | Conditions: Hidradenitis Suppurativa (HS) | NA | Status: RECRUITING